Rani Therapeutics Holdings, Inc. (RANI)
1.37
-0.02
(-1.44%)
USD |
NASDAQ |
Jan 20, 11:40
Rani Therapeutics Holdings EPS Diluted (Quarterly): -0.1165 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Exelixis, Inc. | 0.695 |
| Eli Lilly & Co. | 6.211 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.914M |
| Total Expenses (Quarterly) | 5.412M |
| Enterprise Value | 144.38M |
| Earnings Yield | -57.72% |
| Normalized Earnings Yield | -51.91 |